Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-γ-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4+ T-cell activation

Jeanne M. Soos, Jeffrey I. Krieger, Olaf Stüve, Chelsea L. King, Juan Carlos Patarroyo, Ken Aldape, Karolina Wosik, Anthony J. Slavin, Patricia A. Nelson, Jack P. Antel, Scott S. Zamvil

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Fingerprint Dive into the research topics of 'Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-γ-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4<sup>+</sup> T-cell activation'. Together they form a unique fingerprint.

Medicine & Life Sciences